Regulatory Issues
FDA faults ruling on Paxil ads
Published in Medical Letter on the CDC and FDA, September 22nd, 2002
The FDA's "statement of interest" brief asked U.S. District Judge Mariana Pfaelzer to rescind a decision that grew out of a civil lawsuit. FDA officials said they were worried the ruling improperly interferes with the way the agency regulates drugs and drug companies.
"The FDA is concerned about the ruling," agency spokesman Lawrence Bachorik said. "This is not about a single product or a single company but about FDA's authority over prescription drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cardiovascular Disease
Medical costs of cardiovascular disease related to excess weight estimated at $31 billion - Regulatory Issues
FDA unveils new initiative to enhance pharmaceutical good manufacturing practices - Nicotine Addiction
Cigarette tax hike could save millions of lives - Occupational Health
Report stresses worker protection for homeland security - Public Health
Parents' risky behavior rubs off on children - Ebola Virus
Vaccine effective in mice with cell-mediated immune function - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
